Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC

Mutual interactions between cancer cells and the tumor microenvironment importantly contribute to the development of tyrosine kinase inhibitor (TKI) resistance in patients affected by EGFR-mutant NSCLC. In particular, immune recognition-associated proteins with impact on tumor cell clearance through...

全面介紹

Na minha lista:
書目詳細資料
發表在:Front Immunol
Main Authors: Nigro, Annunziata, Ricciardi, Luca, Salvato, Ilaria, Sabbatino, Francesco, Vitale, Monica, Crescenzi, Maria Assunta, Montico, Barbara, Triggiani, Massimo, Pepe, Stefano, Stellato, Cristiana, Casolaro, Vincenzo, Dal Col, Jessica
格式: Artigo
語言:Inglês
出版: Frontiers Media S.A. 2020
主題:
Immunology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004973/
https://ncbi.nlm.nih.gov/pubmed/32082304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03135
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍